References
- Shah SU, Anjum S, Littler WA. Use of diuretics in cardiovascular disease: (2) hypertension. Postgrad Med J 2004;80:271–276.
- Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–223.
- 1999 World Health Organization - International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999;17:151–183.
- Doshi A, Miller GE. “Statistical Brief #120: Trends in the Use of Diuretics to Treat Hypertension 1997 and 2003”. Medical Expenditure Panel Survey 2006.
- Skibo EB, Huang X, Martinez R, Lemus RH, Craigo WA, Dorr RT. Pyrimidoquinazoline-based antitumor agents. Design of topoisomerase II to DNA cross-linkers with activity against protein kinases. J Med Chem 2002;45:5543–5555.
- Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 1992;358:162–164.
- Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC et al. 3’-Azido-3’-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985;82:7096–7100.
- Koshy MC, Mickley D, Bourgiognie J, Blaufox MD. Physiologic evaluation of a new antihypertensive agent: Prazosin HCI. Circulation 1977;55:533–537.
- Vida J, Yevich J. Burger’s Medicinal Chemistry and Drug Discover, 6th edn. New Jersey: Wiley, 2003: pp 203–205.
- Nomoto S, Teshima T, Wakamiya T, Shiba T. The revised structure of capreomycin. J Antibiot 1977;30:955–959.
- Arnaud MJ. Caffeine, Perspectives from Recent Research. New York: Springer-Verlag, 1984: pp 3–38.
- Foroumadi A, Emami S, Hassanzadeh A, Rajaee M, Sokhanvar K, Moshafi MH, Shafiee A. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives. Bioorg Med Chem Lett 2005;15:4488–4492.
- Polak A, Scholer HJ. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy 1975;21:113–130.
- Furukawa S, Usuda K, Fujieda Y, Tamura T, Miyamoto Y, Hayashi K, Ikeyama S, Goryo M, Okada K. Apoptosis and cell proliferation in rat hepatocytes induced by barbiturates. J Vet Med Sci 2000;62:23–28.
- Terzah MH, Susan MB, Anne Marie L, John K, Barton K, Stacey LB, Mark B, Steven W. Clin Cancer Res 2005;11:1884–1889
- Wallace, Tiernan. US Patent 1967; 3,360,518.
- Spickett RGW, Timmis GM. The synthesis of compounds with potential anti-folic acid activity. Part I. 7-Amino- and 7-hydroxy-pteridines. J Chem Soc 1954;3:2887–2895.
- Mitchell JR, Nelson WL, Potter WZ, Sasame HA, Jollow DJ. Metabolic activation of furosemide to chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther 1976;199:41–52.
- Nolan PJ, D’Arey G. Triamterene drug fever and hepatitis. Med J 1987;147:262.
- Aleem G, Ona A, Sherry FQ. Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido [2,3-d]pyrimidines as dihydrofolate reductase inhibitors. Bioorg Med Chem 2001;9:2929–2935.
- Azam MA, Kumar BRP, Shalini S, Suresh B, Reddy TK, Reddy CD. Synthesis and biological screening of 5-{[(4,6-disubstituted pyrimidine-2-yl)thio]methyl}-N-phenyl-1,3,4-thiadiazol-2-amines. Indian J Pharma Sci 2008;70:672–677.
- Lipschitz WL, Hadidian Z, Kerpesar A. Bioassay of diuretics. J Pharmacol Exp Ther 1943;79:97–110.
- Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467–3474.
- Temperini C, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited—old leads for new applications? Org Biomol Chem 2008;6:2499–2250.
- Supuran CT. Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Des 2008;7:641–648.
- Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
- Vogel HG. Drug Discovery and Evaluation, 2nd edn. New York: Springer-Verlag, Berlin, Heidelberg, 2002, pp 323–325.
- Moss DW, Henderson AK. Clinical Enzymology, Tietz Text Book of Clinical Chemistry, 3rd edn. Philadelphia: W.B. Saunders, 1994, pp 617–721.
- King EJ, Armstrong AR. A convenient method for determining serum and bile phosphatase activity. Can Med Assoc J 1934;31:376–381.
- Reinhold JG. Total Protein Albumin and Globulin. Standard Methods in Clinical Chemistry. New York: Academic Press, 1953, pp 88–90.
- Varley H. Practical Clinical Biochemistry. New Delhi: CBS Publishers and Distributors, 1988, pp 236–238.
- Osel A, Gennaro AR, Martin AN. Remington’s Theory and Practices of Pharmaceutical Sciences,15th edn. Pennsylvania: Mack Publishing Company, Easton, 1975, p 119.
- Dunnet CW. New tables for multiple comparisons with a control. Biometrics 1964;20:482–491.
- Furniss BS, Hannaford AJ, Smith PW, Tatchell AR. Vogel’s Text Book of Practical Organic Chemistry, 5th edn. Singapore: Pearson Education Pvt. Ltd, 2005, 1028–1034.
- Weinstock J, Wilson JW, Wiebelhaus VD, Maass AR, Brennan FT, Sosnowski G. Pteridines XII. Structure activity relationships of some pteridine diuretics. J Med Chem 1968;11:573–579.